New fertility shot aims for 'Just Right' pregnancy odds
NCT ID NCT07153367
Summary
This study is testing a specific, fixed dose of a fertility hormone (Rekovelle) for women undergoing a common fertility procedure called intrauterine insemination (IUI). The goal is to help the ovaries produce the ideal number of eggs—aiming for two—to increase the chance of pregnancy while lowering the risk of having twins or triplets. Researchers want to see if this set dose works well from the first try, making the treatment process simpler and potentially more successful.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabinet Dr Elodie Descat-Polyclinique Jean Villar
RECRUITINGBruges, 33520, France
Contact Email: •••••@•••••
Contact
-
Cabinet Dr Géraldine PORCU-Institut de Médecine de la Reproduction
RECRUITINGMarseille, 13008, France
Contact Email: •••••@•••••
Contact
-
Cabinet Dr Nathalie Massin- Hôpital Américain De Paris
SUSPENDEDNeuilly-sur-Seine, 92200, France
-
Cabinet Dr Nicolas Chevalier-Centre AMP Saint Roch
RECRUITINGMontpellier, 34070, France
Contact Email: •••••@•••••
Contact
-
Chi Creteil
RECRUITINGCréteil, 94000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.